NM_001110792.2:c.1351G>A

Variant summary

Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_001110792.2(MECP2):​c.1351G>A​(p.Ala451Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000378 in 1,209,599 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 138 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00031 ( 0 hom., 9 hem., cov: 22)
Exomes 𝑓: 0.00038 ( 0 hom. 129 hem. )

Consequence

MECP2
NM_001110792.2 missense

Scores

1
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:14

Conservation

PhyloP100: 0.0860
Variant links:
Genes affected
MECP2 (HGNC:6990): (methyl-CpG binding protein 2) DNA methylation is the major modification of eukaryotic genomes and plays an essential role in mammalian development. Human proteins MECP2, MBD1, MBD2, MBD3, and MBD4 comprise a family of nuclear proteins related by the presence in each of a methyl-CpG binding domain (MBD). Each of these proteins, with the exception of MBD3, is capable of binding specifically to methylated DNA. MECP2, MBD1 and MBD2 can also repress transcription from methylated gene promoters. In contrast to other MBD family members, MECP2 is X-linked and subject to X inactivation. MECP2 is dispensible in stem cells, but is essential for embryonic development. MECP2 gene mutations are the cause of most cases of Rett syndrome, a progressive neurologic developmental disorder and one of the most common causes of cognitive disability in females. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.028922886).
BP6
Variant X-154030513-C-T is Benign according to our data. Variant chrX-154030513-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 143458.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154030513-C-T is described in Lovd as [Likely_benign].
BS2
High Hemizygotes in GnomAd4 at 9 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MECP2NM_001110792.2 linkc.1351G>A p.Ala451Thr missense_variant Exon 3 of 3 ENST00000453960.7 NP_001104262.1 P51608-2A0A140VKC4Q59FJ6
MECP2NM_004992.4 linkc.1315G>A p.Ala439Thr missense_variant Exon 4 of 4 ENST00000303391.11 NP_004983.1 P51608-1D3YJ43Q59FJ6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MECP2ENST00000453960.7 linkc.1351G>A p.Ala451Thr missense_variant Exon 3 of 3 1 NM_001110792.2 ENSP00000395535.2 P51608-2
MECP2ENST00000303391.11 linkc.1315G>A p.Ala439Thr missense_variant Exon 4 of 4 1 NM_004992.4 ENSP00000301948.6 P51608-1
MECP2ENST00000628176 linkc.*687G>A 3_prime_UTR_variant Exon 5 of 5 3 ENSP00000486978.1 A0A0D9SFX7
MECP2ENST00000407218.5 linkc.*687G>A downstream_gene_variant 5 ENSP00000384865.2 B5MCB4

Frequencies

GnomAD3 genomes
AF:
0.000314
AC:
35
AN:
111438
Hom.:
0
Cov.:
22
AF XY:
0.000268
AC XY:
9
AN XY:
33608
show subpopulations
Gnomad AFR
AF:
0.000163
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000285
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000472
Gnomad OTH
AF:
0.00133
GnomAD3 exomes
AF:
0.000196
AC:
36
AN:
183263
Hom.:
0
AF XY:
0.000133
AC XY:
9
AN XY:
67729
show subpopulations
Gnomad AFR exome
AF:
0.000228
Gnomad AMR exome
AF:
0.000182
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000144
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000293
Gnomad OTH exome
AF:
0.000441
GnomAD4 exome
AF:
0.000384
AC:
422
AN:
1098161
Hom.:
0
Cov.:
32
AF XY:
0.000355
AC XY:
129
AN XY:
363525
show subpopulations
Gnomad4 AFR exome
AF:
0.000151
Gnomad4 AMR exome
AF:
0.000227
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.000199
Gnomad4 SAS exome
AF:
0.0000923
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000456
Gnomad4 OTH exome
AF:
0.000304
GnomAD4 genome
AF:
0.000314
AC:
35
AN:
111438
Hom.:
0
Cov.:
22
AF XY:
0.000268
AC XY:
9
AN XY:
33608
show subpopulations
Gnomad4 AFR
AF:
0.000163
Gnomad4 AMR
AF:
0.000285
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000472
Gnomad4 OTH
AF:
0.00133
Alfa
AF:
0.000128
Hom.:
1
Bravo
AF:
0.000302
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000446
AC:
3
ExAC
AF:
0.000165
AC:
20
EpiCase
AF:
0.000109
EpiControl
AF:
0.000119

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:14
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
May 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

MECP2: BP4, BS2 -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Mar 08, 2019
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is associated with the following publications: (PMID: 12566531, 10767337, 12872250, 12384770, 16763963) -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

not specified Benign:3
May 08, 2017
Eurofins Ntd Llc (ga)
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 23, 2019
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Severe neonatal-onset encephalopathy with microcephaly Benign:1
Jan 19, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Rett syndrome Benign:1
Aug 14, 2023
Centre for Population Genomics, CPG
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: curation

This variant has been collected from RettBASE and curated to current modified ACMG/AMP criteria.Based on the classification scheme defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders Specifications to the ACMG/AMP Variant Interpretation Guidelines VCEP 2.0, this variant is classified as benign. At least the following criteria are met: The allele frequency of this variant in at least one population in gnomAD is higher than the 0.03% threshold defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders VCEP 2.0 (BA1). -

Inborn genetic diseases Benign:1
May 31, 2018
Ambry Genetics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Attention deficit hyperactivity disorder Benign:1
Apr 26, 2016
RettBASE
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: research

- -

Autism, susceptibility to, X-linked 3 Benign:1
Apr 26, 2016
RettBASE
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: research

- -

X-linked intellectual disability-psychosis-macroorchidism syndrome Benign:1
Apr 26, 2016
RettBASE
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: research

- -

MECP2-related disorder Benign:1
Jun 30, 2021
PreventionGenetics, part of Exact Sciences
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.073
BayesDel_addAF
Benign
-0.27
T
BayesDel_noAF
Benign
-0.33
CADD
Benign
5.1
DANN
Benign
0.75
DEOGEN2
Benign
0.28
T;.
FATHMM_MKL
Benign
0.0079
N
LIST_S2
Benign
0.68
T;T
M_CAP
Benign
0.047
D
MetaRNN
Benign
0.029
T;T
MetaSVM
Benign
-0.67
T
MutationAssessor
Benign
0.0
N;.
PrimateAI
Benign
0.33
T
PROVEAN
Benign
-0.42
N;N
REVEL
Uncertain
0.45
Sift
Benign
0.66
T;T
Sift4G
Benign
0.59
T;T
Polyphen
0.0
B;B
Vest4
0.029
MVP
0.80
ClinPred
0.0040
T
GERP RS
-1.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.2
Varity_R
0.039
gMVP
0.18

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs61753973; hg19: chrX-153295964; API